| 0.9096 -0.034 (-3.55%) | 07-10 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 1.42 | 1-year : | 1.66 |
| Resists | First : | 1.22 | Second : | 1.42 |
| Pivot price | 0.77  |
|||
| Supports | First : | 0.83 | Second : | 0.59 |
| MAs | MA(5) : | 0.95 |
MA(20) : | 0.74 |
| MA(100) : | 0.86 |
MA(250) : | 1.33 |
|
| MACD | MACD : | 0 |
Signal : | 0 |
| %K %D | K(14,3) : | 59.9 |
D(3) : | 71.2 |
| RSI | RSI(14): 60.3 |
|||
| 52-week | High : | 2.69 | Low : | 0.55 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ SKIN ] has closed below upper band by 26.8%. Bollinger Bands are 74.2% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 2 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 1.14 - 1.14 | 1.14 - 1.15 |
| Low: | 0.89 - 0.9 | 0.9 - 0.91 |
| Close: | 0.93 - 0.94 | 0.94 - 0.95 |
The Beauty Health Company is an international enterprise focused on the conceptualization, development, production, promotion, and distribution of advanced aesthetic equipment and beauty solutions. Its leading offering is HydraFacial, a renowned skincare system that works to revitalize the complexion through a multi-step process: deep cleansing, gentle exfoliation, impurity extraction, active ingredient infusion, and intensive hydration, all powered by proprietary blends and specialized serums. Beyond this, their portfolio encompasses Syndeo, a sophisticated HydraFacial Delivery System designed to optimize every phase of the treatment and allow practitioners to tailor experiences to individual client preferences. They also provide the HydraFacial Nation App, a digital tool enabling users to gain insights into their skin's condition, explore various treatment options, and track their progress over subsequent sessions. Another key product is Keravive, a specialized treatment dedicated to fostering scalp health. The company was established in 1997 and maintains its corporate headquarters in Long Beach, California.
Sun, 14 Jun 2026
Beauty Health Company (SKIN) Attempts Recovery: Stock Climbs 1.9% Toward Key Resistance at $0.68 - Narrow Range Breakout - dars.gov.et
Fri, 08 May 2026
Kenvue’s beauty sales soar 8.4% to $1 billion in Q1 2026 - Cosmetics Business
Thu, 07 May 2026
SkinHealth Systems Inc. (SKIN) Reports Q1 Loss, Lags Revenue Estimates - Yahoo Finance
Wed, 29 Apr 2026
SkinHealth Systems schedules May 7 earnings release, 4:30 p.m. call - Stock Titan
Wed, 22 Apr 2026
Three new directors join SkinHealth board ahead of two departures - Stock Titan
Wed, 08 Apr 2026
How The Beauty Health (SKIN) Investment Story Is Shifting With Mixed Analyst Signals - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Consumer Defensive
|
|
|
Industry:
Household & Personal Products
|
|
| Shares Out | 130 (M) |
| Shares Float | 65 (M) |
| Held by Insiders | 13.1 (%) |
| Held by Institutions | 87.9 (%) |
| Shares Short | 12,460 (K) |
| Shares Short P.Month | 16,250 (K) |
| EPS | -0.13 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.47 |
| Profit Margin | -2.1 % |
| Operating Margin | -2.8 % |
| Return on Assets (ttm) | -1.2 % |
| Return on Equity (ttm) | -12 % |
| Qtrly Rev. Growth | -6.7 % |
| Gross Profit (p.s.) | 1.48 |
| Sales Per Share | 2.28 |
| EBITDA (p.s.) | 0.1 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 29 (M) |
| Levered Free Cash Flow | 28 (M) |
| PE Ratio | -7 |
| PEG Ratio | 0.9 |
| Price to Book value | 1.89 |
| Price to Sales | 0.39 |
| Price to Cash Flow | 4.07 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|